Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression
- 16 June 2008
- journal article
- other
- Published by SAGE Publications in Clinical Trials
- Vol. 5 (3) , 253-261
Abstract
Background: To date, no cross-national RCT has addressed the mechanisms underlying the relative success of pharmacological and psychotherapeutic interventions for depression. A multi-site clinical trial that includes psychotherapy as one of the treatments presents numerous challenges related to cross-site consistency and communication. Purpose: This report describes how those challenges were met in the study ``Depression: The Search for Treatment Relevant Phenotypes'', being carried out at the University of Pittsburgh and the University of Pisa, Italy. Methods: Implementing the study required the investigators to address methodological and practical challenges related to the different requirements of the two Institutional Review Boards (IRBs), psychotherapy training, independent evaluator training, patient recruitment, development of common tools for data entry, quality control and generation of weekly reports of patient progress as well as establishing a similar clinical and research framework in two countries with substantially different health care systems. Results: By having bilingual investigators and staff members who spent time at one another's sites, making use of frequent conference-call staff meetings and being flexible within the bounds of the sometimes contradictory requirements of the IRBs, the investigators were able to meet the human subjects protection requirements of both institutions, surmount language barriers to consistent therapist and evaluator training and develop common tools for study management. As a result, recruitment goals were met at both sites and retention rates were high. One instance of inconsistent implementation of the protocol was corrected within the first year. Limitations: This study was conducted in two Western cultures by researchers with long-standing collaboration. Our findings may not be generalizable to other countries or research settings. Conclusions: The implementation of a cross-national protocol and the adoption and maintenance of common procedures is possible when investigators are aware of the challenges this may present and are proactive in trying to address them. Clinical Trials 2008; 5: 253—261. http://ctj.sagepub.comKeywords
This publication has 34 references indexed in Scilit:
- Duloxetine in the prevention of relapse of major depressive disorderThe British Journal of Psychiatry, 2006
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004
- A Comparison of Delivery Methods of Cognitive-Behavioral Therapy for Panic Disorder: An International Multicenter Trial.Journal of Consulting and Clinical Psychology, 2003
- Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptomsDepression and Anxiety, 2002
- The Work and Social Adjustment Scale: a simple measure of impairment in functioningThe British Journal of Psychiatry, 2002
- The EORTC Gastrointestinal Tract Cancer GroupEuropean Journal of Cancer, 2002
- Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program.Journal of Consulting and Clinical Psychology, 1995
- Edinburgh primary care depression study: treatment outcome, patient satisfaction, and cost after 16 weeks.BMJ, 1992
- Interpersonal Psychotherapy (IPT) and Drugs in the Treatment of Depression1,2Pharmacopsychiatry, 1987
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960